Skip to content

US · WLKP · CHEMICALS

Westlake Chemical Partners LP (WLKP) intrinsic value and stock valuation

$20.72as of 2026-11-21 · Mkt cap 763.43M

Data updated · price as of 2026-11-21

Strongly undervaluedIC value is more than 50% above the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Westlake Chemical Partners LP DCF and intrinsic value

InvestorsCraft values WLKP with the Chepakovich two-stage DCF model — currently rated strongly undervalued. How the model works · Run your own DCF prefilled from WLKP’s statements →

Westlake Chemical Partners LP Graham Number

Graham Number: $26.61d — the price is at or below the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Basic Materials · Chemicals Houston, TX 77056 wlkpartners.com

How the business is doing

Fiscal 2011–2025, USD

Revenue
$1.17B+3.8% 5y CAGRd
20112025
Net income
$48.7M-5.9% 5y CAGRd
20112025
Free cash flow
$201.7M-9.7% 5y CAGRd
20112025
Total equity
$802.4M-2.6% 5y CAGRd
20122025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2011–2025, USD
20252024202320222021
Revenue$1.17B$1.14B$1.19B$1.59B$1.21B
Operating income$319.6M$390.4M$357.7M$347.7M$410.7M
Net income$48.7M$62.4M$54.3M$64.2M$82.6M
EPSd$1.38M$1.77M$1.54M$1.82M$2.34M
Operating cash flow$280.5M$485M$452M$463.7M$408.4M
Capital expenditure-$-78.82M-$-48.97M-$-46.82M-$-54.12M-$-81.17M
Free cash flow$201.7M$436M$405.2M$409.6M$327.3M
Total assets$1.26B$1.29B$1.32B$1.37B$1.48B
Total debt$399.7M$399.7M$399.7M$399.7M$399.7M
Net debt$355.4M$341.4M$341.1M$334.9M$382.6M
Total equity$802.4M$829.3M$856.3M$903.7M$972.7M
Cash and short-term investments$44.3M$58.3M$58.6M$64.8M$17.1M
Income statement
20252024202320222021
Revenue$1.17B$1.14B$1.19B$1.59B$1.21B
Cost of revenue$818.9M$717M$803.3M$1.22B$773.2M
Gross profit$347.9M$418.9M$387.5M$377.4M$441.7M
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$28.3M$28.5M$29.8M$29.7M$31M
Other expenses$0.00$0.00$0.00$0.00$0.00
Operating expenses$28.3M$28.5M$29.8M$29.7M$31M
Cost and expenses$847.1M$745.5M$833.1M$1.25B$804.2M
Interest income$0.00$0.00$0.00$0.00$0.00
Interest expense$22.9M$25.7M$26.5M$13.4M$8.82M
Depreciation and amortization$128M$111.9M$110.2M$121.1M$108.8M
Ebitda$450M$507.6M$472.1M$470.3M$519.6M
Operating income$319.6M$390.4M$357.7M$347.7M$410.7M
Total other income/expenses, net-$-20.45M-$-20.45M-$-22.27M-$-11.84M-$-8.75M
Income before tax$299.1M$370M$335.4M$335.9M$401.9M
Income tax expense$550K$830K$810K$1.02M$550K
Net income$48.7M$62.4M$54.3M$64.2M$82.6M
Weighted average shares outstanding$35.2M$35.2M$35.3M$35.2M$35.2M
Weighted average diluted shares outstanding$35.2M$35.2M$35.2M$35.2M$35.2M
Balance sheet
20252024202320222021
Cash and short-term investments$44.3M$58.3M$58.6M$64.8M$17.1M
Net receivables$63.6M$178.1M$162.7M$109.5M$254.9M
Inventory$2.77M$4.06M$4.43M$4.71M$8.9M
Total current assets$143.5M$240.9M$226.2M$245.8M$281.2M
Property, plant and equipment, net$886M$903.6M$943.8M$990.2M$1.04B
Goodwill and intangible assets$5.81M$5.81M$5.81M$5.81M$5.81M
Long-term investments$0.00$0.00$0.00$0.00$0.00
Total non-current assets$1.11B$1.05B$1.09B$1.13B$1.2B
Total assets$1.26B$1.29B$1.32B$1.37B$1.48B
Accounts payable$51.3M$20.7M$31.4M$49.4M$45.9M
Short-term debt$0.00$0.00$0.00$0.00$0.00
Deferred revenue$0.00$0.00$0.00$0.00$0.00
Total current liabilities$51.3M$55.4M$56.3M$66.9M$106.8M
Long-term debt$399.7M$399.7M$399.7M$399.7M$399.7M
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$402.9M$403.3M$404.3M$401.3M$401.2M
Capital lease obligations$0.00$0.00$0.00$0.00$0.00
Total liabilities$454.2M$458.6M$460.6M$468.3M$508M
Common stock$501.1M$518.7M$522.5M$534.5M$536.6M
Retained earnings$0.00$0.00$0.00$0.00$0.00
Accumulated other comprehensive income (loss)$0.00$0.00$0.00$0.00$0.00
Total equity$802.4M$829.3M$856.3M$903.7M$972.7M
Total investments$0.00$0.00$0.00$0.00$0.00
Total debt$399.7M$399.7M$399.7M$399.7M$399.7M
Net debt$355.4M$341.4M$341.1M$334.9M$382.6M
Cash flow statement
20252024202320222021
Net income$298.6M$369.2M$54.3M$334.8M$401.4M
Depreciation and amortization$128M$111.9M$110.2M$121.1M$108.8M
Stock-based compensation$0.00$0.00$350K$280K$440K
Change in working capital-$-148.83M$1.78M$2.26M$7.83M-$-105.68M
Accounts receivable-$-29.55M$33M$28.7M-$-14.44M-$-26.29M
Inventory$1.29M$370K$280K$4.18M-$-5.42M
Accounts payable-$-2.35M-$-2.69M$1.57M-$-17M$19.8M
Net cash provided by operating activities$280.5M$485M$452M$463.7M$408.4M
Investments in property, plant and equipment-$-78.82M-$-48.97M-$-46.82M-$-54.12M-$-81.17M
Acquisitions, net$0.00$0.00$0.00$319.9M$0.00
Net cash used for investing activities$31.2M-$-88.97M-$-75.94M-$-12M-$-64.3M
Common stock issued$0.00$0.00$0.00$0.00$0.00
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid-$-66.45M-$-66.44M-$-66.42M-$-66.41M-$-66.38M
Net cash used for financing activities-$-325.7M-$-396.33M-$-382.23M-$-404.01M-$-344.24M
Net change in cash-$-14.05M-$-300K-$-6.16M$47.7M-$-100K
Cash at end of period$44.3M$58.3M$58.6M$64.8M$17.1M
Operating cash flow$280.5M$485M$452M$463.7M$408.4M
Capital expenditure-$-78.82M-$-48.97M-$-46.82M-$-54.12M-$-81.17M
Free cash flow$201.7M$436M$405.2M$409.6M$327.3M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Westlake Chemical Partners LP

        Westlake Chemical Partners LP concentrates on acquiring, developing, and operating facilities dedicated to ethylene production, along with related infrastructure, throughout the United States. These plants primarily function by converting ethane into ethylene. Furthermore, the partnership distributes a range of chemical co-products—such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen—directly to external buyers, conducting these sales through either immediate spot transactions or established contractual agreements. Westlake Chemical Partners GP LLC serves as the entity's general partner. The company was founded in 2014 and its corporate headquarters are located in Houston, Texas.

        CEO
        Jean-Marc Gilson
        Employees
        2.17K
        Beta
        0.50

        Explore

        Frequently asked questions

        What is the intrinsic value of Westlake Chemical Partners LP (WLKP)?

        Westlake Chemical Partners LP (WLKP) is currently strongly undervalued based on the InvestorsCraft IC model — IC value is more than 50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is WLKP undervalued?

        WLKP trades at a price of $20.72 (Nov 21, 2026): strongly undervalued — IC value is more than 50% above the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.